Get the latest news, insights, and market updates on PGNY (Progyny, Inc.). Explore the news page 3 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.
Galvanize Therapeutics Appoints Laura Francis to its Board of Directors
Galvanize ("Galvanize") Therapeutics, Inc., a commercial-stage medical technology company pioneering pulsed electric field (PEF) therapies for oncology and chronic lung disease, today announced the appointment of Laura Francis to its Board of Directors. Nov 24, 2025 - $PGNY
1 Unpopular Stock That Deserves Some Love and 2 Facing Headwinds
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other business lines such as M&A advisory. Nov 21, 2025 - $PGNY
Merit Medical Systems, Globus Medical, Tenet Healthcare, Progyny, and IQVIA Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated he sees “room for a further adjustment” in the near term, sparking a significant market rally. Following his remarks, the probability of the central bank cutting rates at its December meeting jumped from 39% to over 73%, according to the CME FedWatch tool. This positive sentiment provided relief to Nov 21, 2025 - $PGNY
New Men’s Health Research from Progyny Challenges Conventional Beliefs about Fertility Knowledge and Action
75% of men see fertility as an equal gender topic and acknowledge the connection between fertility health and their overall health, yet only 46% of men with a fertility issue have sought support due to stigma, cost, and other barriers.NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in family building solutions, today announced new men’s health research exploring experiences and views on fertility. The findings shed light on how men in the U.S. view their Nov 20, 2025 - $PGNY
Progyny (PGNY): Gauging Valuation After Recent Share Price Momentum
Progyny (PGNY) shares have gained nearly 9% in the past week and are up 39% over the past month. Investors are keeping a close eye on recent momentum as they weigh the company’s growth story. See our latest analysis for Progyny. The surge in Progyny’s share price this past month hints at renewed optimism around its growth prospects, especially as the 1-year total shareholder return now sits at an impressive 92.95%. Even with periods of volatility, this momentum suggests investors are warming... Nov 18, 2025 - $PGNY
5 Must-Read Analyst Questions From Progyny’s Q3 Earnings Call
Progyny’s third quarter was marked by strong top-line and profitability outperformance, which drew a positive market response. Management attributed these results to robust new client acquisition, the successful addition of over 80 new employer logos, and continued high member engagement. CEO Peter Anevski highlighted the company’s “continued execution” despite macroeconomic headwinds, emphasizing the near 100% renewal rate among existing clients as a critical sign of their market position. The Nov 13, 2025 - $PGNY
We use cookies and similar technologies to collect and process data such as browsing activity or unique identifiers.
Selecting "Allow All" to help us understand site usage and improve the platform.
Choosing "Essential Cookies Only" enables only the cookies necessary for core site functions, such as staying logged in.
For more information, please see our Privacy Policy.
Continue with Google
Continue with Facebook
Continue with Microsoft
Continue with Apple